Literature DB >> 21796109

Acute nicotine-induced tachyphylaxis is differentially manifest in the limbic system.

Yantao Zuo1, Hanbing Lu, D Bruce Vaupel, Yi Zhang, Svetlana I Chefer, William R Rea, Anna V Moore, Yihong Yang, Elliot A Stein.   

Abstract

Rapid tolerance develops to many of nicotine's behavioral and autonomic effects. A better understanding of the spatiotemporal patterns in neuronal activity as a consequence of acute nicotine tolerance (tachyphylaxis) may help explain its commonly found inverted 'U'-shaped biphasic dose-effect relationship on various behaviors. To this end, we employed high-resolution functional magnetic resonance imaging and relative cerebral blood volume (rCBV) as a marker of neuronal activity, to characterize the regional development of acute tolerance as a function of nicotine dose in naïve, anesthetized rats. A single intravenous nicotine injection at 0.1 and 0.3, but not 0.03 mg/kg, significantly increased neuronal activity in many neocortical areas. In contrast, dose-dependent increases in rCBV were most pronounced in limbic regions, such that responses seen at 0.1 mg/kg nicotine in accumbens, hippocampus, amygdala, and several other limbic areas were not seen following 0.3 mg/kg nicotine. Finally, whereas profound tolerance was observed in many cortical regions after the second of two paired nicotine injections at either 0.1 or 0.3 mg/kg, subcortical limbic structures showed only a weak trend for tolerance. Lack of rCBV changes in animals receiving nicotine methiodide, a quaternary nicotine analog that does not cross the blood-brain barrier, supports a direct neuronal effect of nicotine rather than an action on the vasculature. These data provide pharmacodynamic insight into the regional heterogeneity of nicotine tachyphylaxis development, which may be relevant to behavioral and neurobiological mechanisms associated with repeated tobacco consumption.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21796109      PMCID: PMC3194077          DOI: 10.1038/npp.2011.139

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  89 in total

Review 1.  Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators.

Authors:  E L Ochoa; A Chattopadhyay; M G McNamee
Journal:  Cell Mol Neurobiol       Date:  1989-06       Impact factor: 5.046

2.  Selective dopamine antagonists reduce nicotine self-administration.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 3.  Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine.

Authors:  E L Ochoa; L Li; M G McNamee
Journal:  Mol Neurobiol       Date:  1990 Fall-Winter       Impact factor: 5.590

Review 4.  Why some people smoke and others do not: new perspectives.

Authors:  O F Pomerleau; A C Collins; S Shiffman; C S Pomerleau
Journal:  J Consult Clin Psychol       Date:  1993-10

5.  Downregulation of nicotinic receptor function after chronic nicotine infusion.

Authors:  M J Marks; S R Grady; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1993-09       Impact factor: 4.030

6.  Chronic and acute tolerance to subjective effects of nicotine.

Authors:  K A Perkins; J E Grobe; L H Epstein; A Caggiula; R L Stiller; R G Jacob
Journal:  Pharmacol Biochem Behav       Date:  1993-06       Impact factor: 3.533

7.  Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans.

Authors:  K A Perkins; J E Grobe; C Fonte; J Goettler; A R Caggiula; W A Reynolds; R L Stiller; A Scierka; R G Jacob
Journal:  J Pharmacol Exp Ther       Date:  1994-08       Impact factor: 4.030

8.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

9.  Preferential metabolic activation of subcortical brain areas by acute administration of nicotine to rats.

Authors:  D McNamara; D M Larson; S I Rapoport; T T Soncrant
Journal:  J Cereb Blood Flow Metab       Date:  1990-01       Impact factor: 6.200

10.  Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine.

Authors:  T Ren; S M Sagar
Journal:  Brain Res Bull       Date:  1992-11       Impact factor: 4.077

View more
  6 in total

1.  Effect of Abstinence on Audio-Visual Reaction Time in Chronic Smokers Pursuing a Professional Course.

Authors:  Aditya Lal Vallath; Anuradha Rajiv Joshi; Savita Madhukar Vaidya
Journal:  J Clin Diagn Res       Date:  2015-12-01

2.  Rapid sensitization of physiological, neuronal, and locomotor effects of nicotine: critical role of peripheral drug actions.

Authors:  Magalie Lenoir; Jeremy S Tang; Amina S Woods; Eugene A Kiyatkin
Journal:  J Neurosci       Date:  2013-06-12       Impact factor: 6.167

3.  The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity.

Authors:  Luis M Colon-Perez; Kelvin Tran; Khalil Thompson; Michael C Pace; Kenneth Blum; Bruce A Goldberger; Mark S Gold; Adriaan W Bruijnzeel; Barry Setlow; Marcelo Febo
Journal:  Neuropsychopharmacology       Date:  2016-03-21       Impact factor: 7.853

Review 4.  Critical role of peripheral sensory systems in mediating the neural effects of nicotine following its acute and repeated exposure.

Authors:  Eugene A Kiyatkin
Journal:  Rev Neurosci       Date:  2014       Impact factor: 4.353

5.  Evidence of Altered Brain Responses to Nicotine in an Animal Model of Attention Deficit/Hyperactivity Disorder.

Authors:  Guillaume L Poirier; Wei Huang; Kelly Tam; Joseph R DiFranza; Jean A King
Journal:  Nicotine Tob Res       Date:  2017-09-01       Impact factor: 4.244

6.  Acute nicotine administration increases BOLD fMRI signal in brain regions involved in reward signaling and compulsive drug intake in rats.

Authors:  Adrie W Bruijnzeel; Jon C Alexander; Pablo D Perez; Rayna Bauzo-Rodriguez; Gabrielle Hall; Rachel Klausner; Valerie Guerra; Huadong Zeng; Moe Igari; Marcelo Febo
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.